Skip to main content
Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om os
  • Nyheder
  • Instrument service
  • Antimicrobial resistance
  • Messer og udstillinger
  • Aidian Academy
  • Kunde historier
Kontakt os Søg
Logo
Kontakt os
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Point of care
  • QuikRead go-systemet
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • ACRO™ Biotech
  • Hangzhou AllTest Biotech
Læs mere
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Uricult Vet
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Molekylær mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
  • Aidian i Danmark
  • Bestyrelse og direktion
  • Bæredygtighed
  • Kultur
  • Karriere
  • Nyheder
  • Produktnyheder
  • AMR
  • Begivenheder
  • Stories from customers
  • COVID-19
  • Om C-reaktivt protein (CRP)
  • CRP and lower respiratory tract infections
  • Understøttende materialer
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Documents and materials
  • Frequently asked questions
  • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Logo
Kontakt os Tæt
  • Produkter
    • Point of care
      • QuikRead go-systemet
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • ACRO™ Biotech
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Uricult Vet
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Molekylær mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • Luftvejsinfektioner
    • Andre
      • Grifols Promonitor®
  • Om os
    • Aidian i Danmark
    • Bestyrelse og direktion
    • Bæredygtighed
    • Kultur
    • Karriere
  • Nyheder
    • Nyheder
    • Produktnyheder
    • AMR
    • Begivenheder
    • Stories from customers
    • COVID-19
  • Instrument service
  • Antimicrobial resistance
    • Om C-reaktivt protein (CRP)
    • CRP and lower respiratory tract infections
    • Understøttende materialer
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Messer og udstillinger
  • Aidian Academy
    • Generally
    • Product information
    • Documents and materials
    • Frequently asked questions
  • Kunde historier
    • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Populære produkter
AllTest hCG hurtig test

AllTest hCG hurtig test

AllTest MONO hurtig test

AllTest MONO hurtig test

Acro Strep A hurtig test

Acro Strep A hurtig test

Seneste nyt
Se alt

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Increase in influenza and RSV activity in the EU/EEA

14. januar 2025 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...
Nyheder

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Tilbage til alle nyheder
22. marts 2022
Nyheder,
Produktnyheder

Bladder EpiCheck® included in the EAU Clinical Guidelines

Bladder EpiCheck® is a urine marker panel used in the monitoring of non-muscle invasive bladder cancer (NMIBC) to reduce the number of unnecessary cystoscopies. This simple, non-invasive and accurate urine test is newly included in 2022 European Association of Urology (EAU) Clinical Guidelines on NMIBC. The EAU guidelines aim to provide practical recommendations on the clinical management of NMIBC, to assist physicians in making informed treatment decisions with available scientific data. The EAU guidelines state that urinary biomarker tests with high sensitivity and negative predictive values for high-grade disease, including a specific reference to Bladder EpiCheck, might be used to replace and/or postpone cystoscopies in low- and intermediate-risk NMIBC, and reduce the number of cystoscopies in this patient population.

Bladder EpiCheck demonstrated the best performance out of the guideline-recommended markers as measured by diagnostic odds ratios in the recent meta-analysis published in European Urology Oncology1. Bladder EpiCheck analyzes subtle disease-specific changes in DNA methylation markers, allowing for the detection of 91%1 of the high-risk cancers. High risk cancers2 are important to catch as they are aggressive and most likely to progress to invasive cancer if not treated immediately. Bladder EpiCheck has demonstrated a negative predictive value (NPV) of 99% for high-grade cancer, meaning that when receiving a negative Bladder EpiCheck result, there is 99% chance that no high-grade cancer is present1. Overall specificity of Bladder EpiCheck is 85%, ensuring a low rate of false positive results.

Bladder EpiCheck is an objective molecular test meaning that it does not rely on human interpretation. The result is a clear positive/negative for presence of bladder cancer, with additional numerical results between 0-100. The results are not affected by BCG treatment, hematuria or infections.

Aidian is the proud distributor of the Bladder EpiCheck test in the Nordics. More details about the test can be found from product webpages:

Bladder EpiCheck

    Contact us at aidian@aidian.eu for more information on Bladder EpiCheck.


    References

    1. Laukhtina et al., Corrigendum to ‘‘Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis’’ [Eur Urol Oncol 2021;4:927–42], Eur Urol Oncol (2022), https://doi.org/10.1016/j.euo.2022.01.003
    2. EAU (European Association of Urology) Guidelines: Non-muscle-invasive Bladder Cancer. Available at: https://uroweb.org/guidelines/non-muscle-invasive-bladder-cancer/chapter/diagnosis


    Share
    Facebook
    Twitter
    E-mail

    Aidian Denmark ApS

    Ørestads Boulevard 73,
    2300 København S


    +45 8610 3020


    Forespørgsler
    info@aidian.dk


    Salg
    order@aidian.dk

    Selskab
    • Om os
    • Bæredygtighed
    • Karriere
    • Kontakt os
    Produkter
    • Point of care
    • Mikrobiologi
    • Molekylær mikrobiologi
    • Hygiejneovervågning
    • RIA / Collagener
    • Luftvejsinfektioner
    • Andre
    Hurtige links
    • Aidian Academy
    Copyright © 2025 Aidian
    • Persondatapolitik
    • Erklæring om beskyttelse af persondata
    • Cookie-politik
    • Sociale medier politik